Chunfeng Qu

4.3k total citations
81 papers, 2.7k citations indexed

About

Chunfeng Qu is a scholar working on Immunology, Epidemiology and Hepatology. According to data from OpenAlex, Chunfeng Qu has authored 81 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 32 papers in Epidemiology and 18 papers in Hepatology. Recurrent topics in Chunfeng Qu's work include Hepatitis B Virus Studies (24 papers), Immunotherapy and Immune Responses (23 papers) and Liver Disease Diagnosis and Treatment (18 papers). Chunfeng Qu is often cited by papers focused on Hepatitis B Virus Studies (24 papers), Immunotherapy and Immune Responses (23 papers) and Liver Disease Diagnosis and Treatment (18 papers). Chunfeng Qu collaborates with scholars based in China, United States and Australia. Chunfeng Qu's co-authors include Gwendalyn J. Randolph, Claudia Jakubzick, Wanqing Chen, Mengya Zang, Kamal Srivastava, Yuting Wang, Changfa Xia, Hugh A. Sampson, Huan He and Hongmei Zeng and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Chunfeng Qu

77 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunfeng Qu China 30 931 712 662 595 507 81 2.7k
David J. Matthews United States 28 1.2k 1.3× 1.3k 1.8× 316 0.5× 682 1.1× 183 0.4× 61 3.6k
Julio Gutiérrez United States 33 910 1.0× 726 1.0× 895 1.4× 705 1.2× 727 1.4× 82 2.8k
Audrey Sabbagh France 29 635 0.7× 826 1.2× 399 0.6× 188 0.3× 213 0.4× 97 2.9k
Yanbao Yu United States 30 466 0.5× 2.1k 3.0× 607 0.9× 277 0.5× 122 0.2× 98 3.4k
Toru Takahashi Japan 25 309 0.3× 477 0.7× 682 1.0× 258 0.4× 533 1.1× 125 2.5k
Takuya Miyagi Japan 34 1.8k 1.9× 1.3k 1.8× 1.0k 1.6× 774 1.3× 825 1.6× 104 4.0k
Sheng‐Long Ye China 32 415 0.4× 1.5k 2.2× 689 1.0× 1.0k 1.8× 1.5k 2.9× 125 3.8k
Qing Zhu China 36 1.3k 1.4× 2.1k 2.9× 397 0.6× 831 1.4× 71 0.1× 134 4.1k
Yutaka Suehiro Japan 36 628 0.7× 1.6k 2.3× 411 0.6× 1.4k 2.4× 100 0.2× 144 3.5k
Bernard Drénou France 30 1.2k 1.3× 579 0.8× 263 0.4× 797 1.3× 141 0.3× 98 2.8k

Countries citing papers authored by Chunfeng Qu

Since Specialization
Citations

This map shows the geographic impact of Chunfeng Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunfeng Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunfeng Qu more than expected).

Fields of papers citing papers by Chunfeng Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunfeng Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunfeng Qu. The network helps show where Chunfeng Qu may publish in the future.

Co-authorship network of co-authors of Chunfeng Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunfeng Qu. A scholar is included among the top collaborators of Chunfeng Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunfeng Qu. Chunfeng Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qu, Chunfeng, Rongxin He, Wanyin Hou, et al.. (2023). Global burden of neoplasms attributable to specific occupational carcinogens over 30 years: a population-based study. Public Health. 223. 145–155. 1 indexed citations
2.
Chen, Kun, Zhiyuan Wu, Fei Zhao, et al.. (2023). Abnormal generation of IL-17A represses tumor infiltration of stem-like exhausted CD8+ T cells to demote the antitumor immunity. BMC Medicine. 21(1). 315–315. 6 indexed citations
3.
Song, Qianqian, Yuting Wang, Lin Zhou, et al.. (2022). Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection. Science Translational Medicine. 14(672). eabp8704–eabp8704. 40 indexed citations
4.
Cao, Maomao, Lingling Lu, Chunsun Fan, et al.. (2022). Long term outcome of prevention of liver cancer by hepatitis B vaccine: Results from an RCT with 37 years. Cancer Letters. 536. 215652–215652. 21 indexed citations
5.
Ma, Yarui, Junbo Liang, Mo Li, et al.. (2021). AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma. Signal Transduction and Targeted Therapy. 6(1). 299–299. 88 indexed citations
6.
Zhang, Shuguang, et al.. (2021). PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM). Journal of Immunotherapy. 44(6). 214–223. 18 indexed citations
7.
Sheng, Yuling, Kun Chen, Wei Jiang, et al.. (2021). PD-1 restrains IL-17A production from γδ T cells to modulate acute radiation-induced lung injury. Translational Lung Cancer Research. 10(2). 685–698. 17 indexed citations
8.
Chen, Kun, Zhiyuan Wu, Hong Zhao, et al.. (2019). XCL1 / Glypican-3 Fusion Gene Immunization Generates Potent Antitumor Cellular Immunity and Enhances Anti–PD-1 Efficacy. Cancer Immunology Research. 8(1). 81–93. 34 indexed citations
9.
Minko, Irina G., Vladimir L. Vartanian, Paweł Jaruga, et al.. (2019). Characterization of rare NEIL1 variants found in East Asian populations. DNA repair. 79. 32–39. 15 indexed citations
10.
Qu, Chunfeng, Taoyang Chen, Yuting Wang, et al.. (2018). [Primary prevention model of liver cancer in rural China].. PubMed. 40(7). 481–489. 3 indexed citations
11.
Chen, Hongda, Yue Zhang, Siwen Li, et al.. (2018). Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma. Cancer Management and Research. Volume 10. 1947–1958. 45 indexed citations
14.
Zhang, Yue, Chunfeng Qu, Jiansong Ren, et al.. (2015). [Liver cancer incidence and mortality data set in China].. PubMed. 37(9). 705–20. 5 indexed citations
15.
Wang, Liming, Mengya Zang, Weiqi Rong, et al.. (2015). [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].. PubMed. 37(1). 5–10. 3 indexed citations
16.
Zhang, Tongwen, Jiang Chang, Dianke Yu, et al.. (2012). Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma. Human Molecular Genetics. 22(6). 1262–1269. 47 indexed citations
17.
Xu, Libin, Yong Wei, Taoyang Chen, et al.. (2010). Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination. Vaccine. 28(37). 5986–5992. 47 indexed citations
18.
Qu, Chunfeng, Van Anh Nguyen, Miriam Mérad, & Gwendalyn J. Randolph. (2009). MHC Class I/Peptide Transfer between Dendritic Cells Overcomes Poor Cross-Presentation by Monocyte-Derived APCs That Engulf Dying Cells. The Journal of Immunology. 182(6). 3650–3659. 54 indexed citations
19.
Srivastava, Kamal, Chunfeng Qu, Tengfei Zhang, et al.. (2009). Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-γ–producing CD8+ T cells. Journal of Allergy and Clinical Immunology. 123(2). 443–451. 91 indexed citations
20.
Zhan-qiu, Yang, et al.. (2007). Separation and anti-Hantaan virus activity of extracts from Alternanthera philoxcroides in vitro and in vivo. Wuhan University Journal of Natural Sciences. 12(6). 1143–1147. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026